PYMNTS.com January 19, 2025

Will 2025 bring an end to a fallow period for medical device company IPOs?

As the Financial Times (FT) reported Sunday (Jan. 19) a pair of initial public offerings (IPO) by cardiac device makers could be a sign that a dearth in medical tech listings is soon to end.

Sources told the FT that Kestra Medical Technologies and Heartflow, which both make non-invasive cardiac tests for patients with heart conditions, have recently hired advisers to prepare for IPOs. These listings could happen as soon as the first half of the year, one source said.

The report said high interest rates and a lackluster performance by other medical companies that went public during the pandemic has led investors to cool on...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Medical Devices, Trends
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment
Canon Healthcare investing $34M to open new US headquarters, imaging resource center

Share This Article